Urinary Incontinence/Overactive Bladder

Editor's Choice

Male stress urinary incontinence patients can be treated effectively with artificial urinary sphincter

The artificial urinary sphincter appears to be efficacious for the treatment of male stress urinary incontinence, even in complex patients with histories of radiation therapy or urethral surgery.

LATEST ARTICLES

FDA approves Botox to treat a form of urinary incontinence

FDA has approved onabotulinumtoxinA (Botox, Allergan) for injection for the treatment of urinary incontinence resulting from detrusor overactivity associated with a neurologic condition (e.g., spinal cord injury [SCI], multiple sclerosis [MS]) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

Refractory urge incontinence: Conservative, non-drug therapies

In patients with refractory urge incontinence, a variety of non-pharmacologic therapeutic options can be used as an alternative or complement to anticholinergic medications. Maximizing conservative measures, namely behavioral therapy and physical therapy, offers multiple benefits and adds little risk for the majority of patients.

New Tool: Rx Adherence Predictor

Now you can determine in advance the likelihood of a patient filling and staying on their medications. This tool can support your ability to prioritize and target patients who may benefit from counseling about the importance of maintaining your prescribed drug regimen.

Transvaginal mesh for pelvic prolapse: Avoiding and managing complications

The increasing popularity of synthetic mesh to treat pelvic organ prolapse has led to a rise in the incidence of certain unique mesh-related complications, including extrusion, erosion, and pain, in a minority of patients. Management of these events is generally straightforward and leads to resolution of bothersome symptoms in the vast majority of patients.

Physician’s Focus: Botox for Urologic Conditions

Although botulinum neurotoxins are currently being evaluated for urologic disorders and are not yet FDA-approved, results from a 2005 study show that Botulinum toxin Type A can significantly decrease signs and symptoms of urinary incontinence. ModernMedicine provides several thought-provoking articles on this topic.